In:
Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 62, No. suppl_1 ( 2013-09)
Abstract:
Serotonin (5HT) and NADPH oxidases (Nox) have been linked to the pathology of pulmonary arterial hypertension (PAH). However, it is unclear whether 5HT plays a role in PAH through Nox-dependent mechanisms. We hypothesised that 5HT through Nox1-induced reactive oxygen species (ROS) induces PASMC damage. Human PASMC primary cultures were stimulated with 5HT (1μM) in the absence/presence of tempol (antioxidant, 10μmol/L), ML171 (Nox1 inhibitor; 1μM), and EHT1864 (Rac1 inhibitor; 100μM). ROS generation was assessed by chemiluminescence. Markers of fibrosis (fibronectin), growth (PCNA), inflammation (TRAIL, DcR2), Nrf2 regulation (Nrf2, BACH1, HO1) and MAPKs activation (ERK1/2 and p38MAPK) were analyzed by immunoblotting. Proliferation was assessed by [3H] -thymidine incorporation in the presence/absence of Nox1 inhibitor. 5HT induced increased in ROS production at 4h of stimulation (224 ± 49% vs vehicle; p 〈 0.05) in PASMC, an effect blocked by tempol, EHT1864 and ML171. Fibronectin (192 ± 26%), PCNA (124 ± 2%), TRAIL (122 ± 4%) and DcR2 (133 ± 2%) protein levels were increased by 5HT in PASMCs (p 〈 0.05, vs vehicle). In addition, 5HT increased phosphorylation of ERK1/2 (169 ± 10%) and p38MAPK (157 ± 15%) (p 〈 0.05, vs vehicle). Levels of Nrf2 and its downstream target, HO-1, were decreased by 5HT stimulation (90 ± 1%; 84 ± 6% respectively vs vehicle 100%, p 〈 0.05). BACH1 expression, a protein that negatively modulates antioxidant regulator Nrf2, was increased by 5HT in PASMCs (153 ± 8% vs vehicle; p 〈 0.05). Nox1, but not Nox2, expression was increased in PASMC after stimulation with 5HT (139 ± 11% vs vehicle, p 〈 0.05). 5HT induced a 3.95±0.39 fold increase in proliferation PASMCs (P 〈 0.05), which was blocked by ML171. In conclusion, Nox1 may play a role in 5HT-induced pro-proliferative, fibrotic and inflammatory responses. These data highlight some molecular mechanisms whereby 5HT may exert deleterious vascular effects in PAH.
Type of Medium:
Online Resource
ISSN:
0194-911X
,
1524-4563
DOI:
10.1161/hyp.62.suppl_1.A264
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2013
detail.hit.zdb_id:
2094210-2
